Tokuwa Kanno

Tokuwa Kanno is an accomplished professional in the field of computational biology, currently serving as the Director of Oncology Computational Biology at GSK since January 2023. Previously, Tokuwa held the position of Senior Principal Scientist at Sanofi from January 2022 to January 2023, and worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as both a Senior Scientist (Computational Biology) and Computational Scientist from February 2018 to January 2022. Tokuwa's academic foundations include a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from King's College London, where research was conducted from June 2012 to January 2016, and a postdoctoral role at the same institution from October 2016 to February 2018.